Glucagon · source year
2 selected, source-linked Glucagon records carrying a 2020 source date. This is a navigational view of PeptideScanner’s selected coverage—not a complete research timeline or a statement about safety or effectiveness.
2 selected records.
2 represented types.
2 distinct public records.
Cited chronology
Regulatory
The official Drugs@FDA dataset lists original submission 1 for ANDA 208086 with status AP dated 2020-12-28, and names glucagon among the application record's active ingredients.
Source: Drugs@FDA via openFDA ↗
Clinical trials
PeptideScanner retained ClinicalTrials.gov record NCT03770637 at 2026-07-30T20:27:50.524Z. Its registry update date was 2020-05-21, and PeptideScanner's reviewed identity mapping was glucagon.
Source: ClinicalTrials.gov ↗